DSpace at RU >

Browsing by Author Cats, A.

Full Text	Issue Date	Title	Author(s)
	2003	Kanker: eindigheid, zin en spiritualiteit : een samenwerkingsproject	Staps, T.; Yang, W.; Hijmans, E.J.S., et al
	2007	Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer.	Vrieling, A.; Voskuil, D.W.; Bonfrer, J.M.G., et al
	2008	No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer.	Vrieling, A.; Rookus, M.A.; Kampman, E., et al
	2010	One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.	Vasen, H.F.; Abdirahman, M.; Brohet, R., et al
	2007	Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group.	Hospers, G.; Punt, C.J.A.; Tesselaar, M.E., et al
	2005	Prevalence of adenomas among young individuals at average risk for colorectal cancer.	Jong, A.E. de; Morreau, H.; Nagengast, F.M., et al
	2012	Quality of life after surgery for colon cancer in patients with Lynch syndrome: partial versus subtotal colectomy.	Haanstra, J.F.; Vos tot Nederveen Cappel, W.H. de; Gopie, J.P., et al
	2008	A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity.	Tol, J.; Koopman, M.; Rodenburg, C.J., et al
	2010	Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits.	Lammens, C.R.; Bleiker, E.M.A.; Aaronson, N.K., et al
	2011	Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer	Deenen, M.J.; Tol, J.; Burylo, A.M., et al
	2004	The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC.	Jong, A.E. de; Morreau, H.; Puijenbroek, M., et al
	2004	Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer.	Vos tot Nederveen Cappel, W.H. de; Meulenbeld, H.J.; Kleibeuker, J.H., et al
	2006	What is the appropriate screening protocol in Lynch syndrome?	Jong, A.E. de; Nagengast, F.M.; Kleibeuker, J.H., et al